tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BEAM Stock Latest News

Private Markets: Dyna Robotics raises $120M from Nvidia, Amazon
The FlyPrivate Markets: Dyna Robotics raises $120M from Nvidia, Amazon
18d ago
V
MA
Cathie Wood Invests $37M into Biotech Stocks, Trims Stake in KTOS, TEM, and ROKU Stocks
PremiumMarket News
Cathie Wood Invests $37M into Biotech Stocks, Trims Stake in KTOS, TEM, and ROKU Stocks
19d ago
TEM
ARCT
Cathie Wood’s ARK Investment buys 491K shares of Beam Therapeutics today
PremiumThe Fly
Cathie Wood’s ARK Investment buys 491K shares of Beam Therapeutics today
19d ago
BEAM
Cathie Wood Bets on AMD, Bullish, and Figma; Trims Tempus AI, Roku
PremiumMarket News
Cathie Wood Bets on AMD, Bullish, and Figma; Trims Tempus AI, Roku
20d ago
AMD
FIG
Beam Therapeutics: Strong Buy Rating Backed by Advancements in Genetic Medicine Programs
PremiumRatings
Beam Therapeutics: Strong Buy Rating Backed by Advancements in Genetic Medicine Programs
22d ago
BEAM
Strategic Positioning and Technological Advancements Drive Buy Rating for Beam Therapeutics
PremiumRatingsStrategic Positioning and Technological Advancements Drive Buy Rating for Beam Therapeutics
27d ago
BEAM
Beam competitive position intact after Wave data, says Clear Street
Premium
The Fly
Beam competitive position intact after Wave data, says Clear Street
1M ago
WVE
BEAM
Wall Street Sees Massive Growth Potential in These 3 Russell 2000 Stocks
Premium
Market News
Wall Street Sees Massive Growth Potential in These 3 Russell 2000 Stocks
1M ago
APGE
BEAM
Cathie Wood ‘Buys the Dip’ in Robinhood, CRISPR, and Beam Therapeutics Stocks
PremiumMarket News
Cathie Wood ‘Buys the Dip’ in Robinhood, CRISPR, and Beam Therapeutics Stocks
2M ago
TXG
WGS
Cathie Wood’s ARK Investment buys 509.6K shares of Beam Therapeutics today
PremiumThe Fly
Cathie Wood’s ARK Investment buys 509.6K shares of Beam Therapeutics today
2M ago
BEAM
Cathie Wood Pours Over $46M into Biotech Stocks, 8/19/2025
PremiumMarket News
Cathie Wood Pours Over $46M into Biotech Stocks, 8/19/2025
2M ago
WGS
BEAM
Cathie Wood’s ARK Investment buys 395K shares of Beam Therapeutics today
PremiumThe Fly
Cathie Wood’s ARK Investment buys 395K shares of Beam Therapeutics today
2M ago
BEAM
Beam Therapeutics announces U.S. FDA granted RMAT to BEAM-101
PremiumThe FlyBeam Therapeutics announces U.S. FDA granted RMAT to BEAM-101
2M ago
BEAM
3 Small-Cap Stocks That Could Double Your Money, According to Analysts
Premium
Market News
3 Small-Cap Stocks That Could Double Your Money, According to Analysts
2M ago
AIOT
BEAM
Beam Therapeutics: Strong Buy Rating Backed by Promising Trials and Solid Financial Position
Premium
Ratings
Beam Therapeutics: Strong Buy Rating Backed by Promising Trials and Solid Financial Position
2M ago
BEAM
Private Markets: Canva draws attention as IPO candidate following Figma debut
PremiumThe Fly
Private Markets: Canva draws attention as IPO candidate following Figma debut
2M ago
BA
CAI
Beam Therapeutics: Promising Advancements in Genetic Medicine with Upcoming Catalysts Justifying Buy Rating
PremiumRatings
Beam Therapeutics: Promising Advancements in Genetic Medicine with Upcoming Catalysts Justifying Buy Rating
2M ago
BEAM
Positive Developments and Financial Strength Bolster Beam Therapeutics’ Buy Rating
PremiumRatings
Positive Developments and Financial Strength Bolster Beam Therapeutics’ Buy Rating
2M ago
BEAM
Beam Therapeutics Reports Q2 2025 Financial Results
PremiumCompany Announcements
Beam Therapeutics Reports Q2 2025 Financial Results
2M ago
BEAM
Beam Therapeutics sees cash runway into 2028
PremiumThe FlyBeam Therapeutics sees cash runway into 2028
2M ago
BEAM
Beam Therapeutics reports Q2 EPS ($1.00), consensus ($1.09)
Premium
The Fly
Beam Therapeutics reports Q2 EPS ($1.00), consensus ($1.09)
2M ago
BEAM
Beam Therapeutics provides updata on BEAM-302 development progress
Premium
The Fly
Beam Therapeutics provides updata on BEAM-302 development progress
2M ago
BEAM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >